Quick Answer
ENvue Medical, Inc. reported Total Revenue of $2.56 million for fiscal year 2024.
ENvue Medical, Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.56M +12.0% |
$2.28M +203.6% |
$752.0K -55.6% |
$1.70M +172.1% |
$623.0K +17.5% |
$530.0K +66.7% |
| Revenue (ASC 606) | $2.56M +12.0% |
$2.28M +203.6% |
$752.0K -55.6% |
$1.70M +172.1% |
$623.0K +17.5% |
$530.0K +66.7% |
| Net Income | -$3.71M +0.2% |
-$3.71M +31.9% |
-$5.45M +61.9% |
-$14.28M -230.1% |
-$4.33M +25.3% |
-$5.79M -39.5% |
| Diluted EPS | -$13.73 +41.1% |
-$23.32 -507.3% |
-$3.84 | — | — | — |
| Total Assets | $3.63M -45.6% |
$6.67M +13.5% |
$5.88M -31.8% |
$8.62M +4.8% |
$8.23M +304.2% |
$2.04M +28.9% |
| Cash and Equivalents | — | — | — | $7.74M +8.3% |
$7.14M +433.8% |
$1.34M +49.3% |
| Stockholders Equity | $627.0K -84.3% |
$3.99M +23.4% |
$3.23M -48.8% |
$6.31M +163.7% |
$2.39M +77.7% |
$1.35M +190.9% |
| R&D Expense | $909.0K +391.4% |
$185.0K -34.6% |
$283.0K -3.4% |
$293.0K +71.3% |
$171.0K -66.7% |
$514.0K -16.3% |
| Operating Income | -$3.58M -4.2% |
-$3.44M +31.4% |
-$5.01M +11.8% |
-$5.68M -20.4% |
-$4.72M +8.4% |
-$5.15M -19.7% |
| Gross Profit | $1.51M -1.9% |
$1.54M +820.4% |
$167.0K -78.3% |
$770.0K +259.8% |
$214.0K -23.8% |
$281.0K +75.6% |
| Shares Outstanding | 378,941 +103.7% |
186,028 -88.7% |
1.64M +17.2% |
1.40M -92.9% |
19.85M +372.2% |
4.20M +10.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $722.0K | +92.0% | +46.2% |
| Revenue (ASC 606) | September 30, 2025 | $722.0K | +92.0% | +46.2% |
| Net Income | September 30, 2025 | $510.0K | +151.1% | +112.8% |
| Diluted EPS | September 30, 2025 | -$0.91 | +74.4% | +11.7% |
| Total Assets | September 30, 2025 | $54.38M | +1061.5% | +5.6% |
| Cash and Equivalents | September 30, 2025 | $6.95M | +432.6% | +72.5% |
| Stockholders Equity | September 30, 2025 | $42.46M | +2168.4% | +4.9% |
| R&D Expense | September 30, 2025 | $221.0K | -11.2% | -77.3% |
| Operating Income | September 30, 2025 | -$2.25M | -131.6% | +43.5% |
| Gross Profit | September 30, 2025 | $189.0K | +42.1% | +640.0% |
| Shares Outstanding | September 30, 2025 | 1.01M | -63.7% | +10110760.0% |
- ENvue Medical, Inc. reported Total Revenue of $2.56 million for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +12.0% in Total Revenue compared to the prior fiscal year.
- ENvue Medical, Inc. reported Revenue (ASC 606) of $2.56 million for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +12.0% in Revenue (ASC 606) compared to the prior fiscal year.
- ENvue Medical, Inc. reported Net Income of -$3.71 million for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +0.2% in Net Income compared to the prior fiscal year.
- ENvue Medical, Inc. reported Diluted EPS of $13.73 per share (loss) for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +41.1% in Diluted EPS compared to the prior fiscal year.
- ENvue Medical, Inc. reported Total Assets of $3.63 million for fiscal year 2024.
- ENvue Medical, Inc. showed a decrease of -45.6% in Total Assets compared to the prior fiscal year.
- ENvue Medical, Inc. reported Cash and Equivalents of $7.74 million for fiscal year 2021.
- ENvue Medical, Inc. showed an increase of +8.3% in Cash and Equivalents compared to the prior fiscal year.
- ENvue Medical, Inc. reported Stockholders Equity of $627.0 thousand for fiscal year 2024.
- ENvue Medical, Inc. showed a decrease of -84.3% in Stockholders Equity compared to the prior fiscal year.
- ENvue Medical, Inc. reported R&D Expense of $909.0 thousand for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +391.4% in R&D Expense compared to the prior fiscal year.
- ENvue Medical, Inc. reported Operating Income of -$3.58 million for fiscal year 2024.
- ENvue Medical, Inc. showed a decrease of -4.2% in Operating Income compared to the prior fiscal year.
- ENvue Medical, Inc. reported Gross Profit of $1.51 million for fiscal year 2024.
- ENvue Medical, Inc. showed a decrease of -1.9% in Gross Profit compared to the prior fiscal year.
- ENvue Medical, Inc. reported Shares Outstanding of 378.9 thousand shares for fiscal year 2024.
- ENvue Medical, Inc. showed an increase of +103.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: